A study supported by the National Institutes of Health found that passive immunotherapies that use broadly neutralizing antibodies could prevent the transmission of HIV. In a laboratory experiment, researchers found that the PGT121, VRC01 and VRC03 antibodies stopped the virus from entering CD4+ T cells obtained from HIV-negative volunteers.

Related Summaries